Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
ACS Omega|November 8, 2021
Noninvasive Tracking of Natural Killer Cells Using Gold NanoparticlesKaterina Shamalov, Rinat Meir, Menachem Motiei, et al.Oncoimmunology|May 17, 2017
The mutational status of p53 can influence its recognition by human T-cellsKaterina Shamalov, Shlomo N Levy, Miryam Horovitz-Fried, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 13, 2013
Human T cells engineered to express a programmed death 1/28 costimulatory retargeting molecule display enhanced antitumor activityChen Ankri, Katerina Shamalov, Miryam Horovitz-Fried, et al.Experientia Supplementum (2012)|February 15, 2022
Adoptive T-cell Immunotherapy: Perfecting Self-DefensesRaphaëlle Toledano Zur, Galit Adler, Katerina Shamalov, et al.ACS Nano|October 14, 2017
Fast Image-Guided Stratification Using Anti-Programmed Death Ligand 1 Gold Nanoparticles for Cancer ImmunotherapyRinat Meir, Katerina Shamalov, Tamar Sadan, et al.Nanomedicine (London, England)|July 21, 2018
Uptake mechanism of metabolic-targeted gold nanoparticlesTamar Dreifuss, Tal-Shachar Ben-Gal, Katerina Shamalov, et al.Frontiers in Immunology|November 1, 2017
Targeting Multiple Tumors Using T-Cells Engineered to Express a Natural Cytotoxicity Receptor 2-Based Chimeric ReceptorVasyl Eisenberg, Katerina Shamalov, Shimrit Meir, et al.Oncotarget|April 21, 2017
A novel lncRNA, GASL1, inhibits cell proliferation and restricts E2F1 activityLital Gasri-Plotnitsky, Aviv Ovadia, Katerina Shamalov, et al.ACS Nano|June 4, 2015
Nanomedicine for Cancer Immunotherapy: Tracking Cancer-Specific T-Cells in Vivo with Gold Nanoparticles and CT ImagingRinat Meir, Katerina Shamalov, Oshra Betzer, et al.Scientific Reports|October 29, 2015
In-vitro Optimization of Nanoparticle-Cell Labeling Protocols for In-vivo Cell Tracking ApplicationsOshra Betzer, Rinat Meir, Tamar Dreifuss, et al.Pageof 2